Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Soliton, Inc.
The request for additional records delays the deal, and could indicate that the commission has specific concerns about the merger between the Botox vendor and an aesthetic device manufacturer.
Also, deals involving AbCellera/Angios, AstraZeneca/Alchemab, Kowa/Esteve, OSE/Veloxis, Tris/Park, Core One/Akome and Vertex/Obsidian.
- Radiofrequency Devices
Surgical Equipment & Devices
- Minimally or Less Invasive